Castle’s DecisionDx-Melanoma Test Can Identify Melanoma Patients with Low Risk of Sentinel Lymph Node Positivity Who Can Forego Biopsy

September 11, 2024

Turning the Tables on Skin Cancer: Melanoma Risk, Mortality Declining Among Young Adults in Sweden

September 9, 2024

Is Melanoma More Lethal in Men Because of Age-related Changes in Fibroblasts?

September 6, 2024

Precancerous MBL Linked to Heightened Melanoma Risk

September 6, 2024

Castle’s DecisionDx-SCC Test Predicts Likelihood of Benefit From Adjuvant Radiation Therapy in SCC

September 5, 2024

Study: Veterans at Higher Risk for Sunburns, Skin Cancers

September 4, 2024

Keytruda Disappoints in Phase III SCC Trial; Merck Halts Study

August 30, 2024

Full Dermal Visualization Improves Efficacy, Lowers Toxicity During Image-Guided SRT for NMSC

August 26, 2024

Time Magazine’s 2024 Kid of the Year Develops Soap That May Deliver Skin Cancer Medication

August 18, 2024

DermBiont’s SM-020 Produces “Prompt, Visible, and Robust” Tumor Responses in BCC

August 15, 2024

Topline Results: Verrica’s VP-315 Performs Well in BCC Trial

August 14, 2024

Distinct Pattern in Protein Production May Predict Severe Side Effects From Melanoma Treatment

August 8, 2024